Thalomid (thalidomide) is distributed by Celgene Corporation, the rights holder of this product. Celgene is also the exclusive manufacturer of Thalomid (thalidomide). Thalomid (thalidomide) was approved for treatment of lesions associated with erythema nodosum leprosum in 1998, and was approved for treatment of multiple myeloma in 2006. Thalomid (thalidomide) is highly regulated in Canada and the United States. In Canada and the United States, only registered prescribers and pharmacists registered with Celgene’s distribution programs can prescribe and dispense Thalomid (thalidomide). Thalomid (thalidomide) is not available from Candrug pharmacy. Candrug pharmacy is not registered with Celgene’s restricted distribution program in Canada or the United States. In order to purchase Thalomid (thalidomide) online, all users must register with Celgene and meet the conditions of Celgene’s restricted RevAid® Program in Canada and RevAssist® program in the United States.
This offer is neither endorsed nor authorized by Celgene Corporation (the United States and Canadian distributor of Thalomid (thalidomide)). Candrug has no affiliation whatsoever with Celgene Corporation.